{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:09:49Z","timestamp":1762160989140},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/bf03297632","type":"journal-article","created":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T18:01:17Z","timestamp":1361469677000},"page":"207-211","source":"Crossref","is-referenced-by-count":5,"title":["Omega-3 in Antiarrhythmic Therapy"],"prefix":"10.1007","volume":"19","author":[{"given":"Claudio","family":"Borghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilenia","family":"Pareo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,29]]},"reference":[{"key":"7632_CR1","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2011.06.063","volume":"58","author":"D Mozaffarian","year":"2011","unstructured":"Mozaffarian D. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 2011; 58: 2047\u201367","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"7632_CR2","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa012918","volume":"346","author":"CM Albert","year":"2002","unstructured":"Albert CM, Campos H, Stampfer MJ, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002 Apr 11; 346(15): 1113\u20138","journal-title":"N Engl J Med"},{"key":"7632_CR3","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa012918","volume":"346","author":"CM Albert","year":"2002","unstructured":"Albert CM, Campos H, et al. Blood levels of long chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002; 346: 1113\u20138","journal-title":"N Engl J Med"},{"key":"7632_CR4","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.jacc.2005.02.079","volume":"45","author":"L Cal\u00f2","year":"2005","unstructured":"Cal\u00f2 L, Bianconi L, Colivicchi F, et al. n-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 2005; 45: 1723\u20138","journal-title":"J Am Coll Cardiol"},{"key":"7632_CR5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","volume":"354","author":"Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto mio-cardico.","year":"1999","unstructured":"Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto mio-cardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354: 447\u201355","journal-title":"Lancet"},{"key":"7632_CR6","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/jama.1995.03530170043030","volume":"274","author":"DS Siscovick","year":"1995","unstructured":"Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995; 274: 1363\u20137","journal-title":"JAMA"},{"key":"7632_CR7","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1161\/01.CIR.0000069566.78305.33","volume":"107","author":"A Leaf","year":"2003","unstructured":"Leaf A, Kang JX, Xiao YF, et al. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 2003; 107: 2646\u201352","journal-title":"Circulation"},{"key":"7632_CR8","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","volume":"142","author":"DY Oh","year":"2010","unstructured":"Oh DY, Talukdar S, Bae EJ, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010; 142: 687\u201398","journal-title":"Cell"},{"key":"7632_CR9","doi-asserted-by":"crossref","first-page":"a2931","DOI":"10.1136\/bmj.a2931","volume":"337","author":"H Leon","year":"2008","unstructured":"Leon H, Shibata MC, Sivakumaran S, et al. Effect of fish oil on arrhythmias and mortality: systematic review. BMJ 2008; 337: a2931","journal-title":"BMJ"},{"issue":"3","key":"7632_CR10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1023\/A:1007757724505","volume":"11","author":"RB Singh","year":"1997","unstructured":"Singh RB, Niaz MA, Sharma JP, et al. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival 4. Cardiovasc Drugs Ther 1997; 11(3): 485\u201391","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"7632_CR11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/ajcn\/74.1.50","volume":"74","author":"DW Nilsen","year":"2001","unstructured":"Nilsen DW, Albrektsen G, Landmark K, et al. Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Am J Clin Nutr 2001; 74(1): 50\u20136","journal-title":"Am J Clin Nutr"},{"key":"7632_CR12","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1161\/CIRCULATIONAHA.105.549527","volume":"112","author":"A Leaf","year":"2005","unstructured":"Leaf A, Albert CM, Josephson M, et al. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 2005; 112: 2762\u20138","journal-title":"Circulation"},{"key":"7632_CR13","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1001\/jama.293.23.2884","volume":"293","author":"MH Raitt","year":"2005","unstructured":"Raitt MH, Connor WE, Morris C, et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA 2005; 293: 2884\u201391","journal-title":"JAMA"},{"key":"7632_CR14","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","volume":"369","author":"M Yokoyama","year":"2007","unstructured":"Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007; 369: 1090\u20138","journal-title":"Lancet"},{"key":"7632_CR15","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(08)61239-8","volume":"372","author":"GISSI-HF investigators.","year":"2008","unstructured":"GISSI-HF investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008; 372: 1223\u201330","journal-title":"Lancet"},{"issue":"21","key":"7632_CR16","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1161\/CIRCULATIONAHA.110.948562","volume":"122","author":"B Rauch","year":"2010","unstructured":"Rauch B, Schiele R, Schneider S, et al., OMEGA Study Group. OMEGA, a randomized, placebo controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline adjusted therapy after myocardial infarction. Circulation 2010; 122(21): 2152\u20139","journal-title":"Circulation"},{"issue":"3","key":"7632_CR17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0002-9149(96)00285-8","volume":"78","author":"C Borghi","year":"1996","unstructured":"Borghi C, Ambrosioni E, Magnani B. Effects of the early administration of zofenopril on onset and progression of congestive heart failure in patients with anterior wall acute myocardial infarction. Am J Cardiol 1996; 78(3): 317\u201322","journal-title":"Am J Cardiol"},{"key":"7632_CR18","first-page":"S24","volume":"32","author":"C Borghi","year":"1998","unstructured":"Borghi C, Ambrosioni E. Evidence-based medicine and ACE inhibition. J Cardiovasc Pharmacol 1998; 32: S24\u201335","journal-title":"J Cardiovasc Pharmacol"},{"key":"7632_CR19","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.295.22.2613","volume":"295","author":"IA Brouwer","year":"2006","unstructured":"Brouwer IA, Zock PL, Camm AJ, et al. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA 2006; 295: 2613\u20139","journal-title":"JAMA"},{"key":"7632_CR20","first-page":"1","volume":"381","author":"I Savelieva","year":"2010","unstructured":"Savelieva I, Kourliouros A, Camm J. Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance. Naunyn Schmiedebergs Arch Pharmacol 2010; 381: 1\u201313","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"7632_CR21","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eur002","volume":"13","author":"I Savelieva","year":"2011","unstructured":"Savelieva I, Kakouros N, Kourliouros A, et al. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines, part I: primary prevention. Europace 2011; 13: 308\u201328","journal-title":"Europace"},{"key":"7632_CR22","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/hrt.2010.215350","volume":"97","author":"T Liu","year":"2011","unstructured":"Liu T, Korantzopoulos P, Shehata M, et al. Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials. Heart 2011; 97: 1034\u201340","journal-title":"Heart"},{"key":"7632_CR23","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.111.022194","volume":"124","author":"S Nodari","year":"2011","unstructured":"Nodari S, Triggiani M, Campia U, et al. n-3 Polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective randomized study. Circulation 2011; 124: 1100\u20136","journal-title":"Circulation"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03297632.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03297632\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03297632","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:28:14Z","timestamp":1562718494000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03297632"}},"subtitle":["Cons Position"],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["7632"],"URL":"https:\/\/doi.org\/10.1007\/bf03297632","relation":{},"ISSN":["1120-9879","1179-1985"],"issn-type":[{"value":"1120-9879","type":"print"},{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}